Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| APO-METOPROLOL SR | APOTEX INC | Actual shortage | 100MG | Updated Report | 2020-01-27 | 98569 |
| APIDRA | SANOFI-AVENTIS CANADA INC | Actual shortage | 100UNIT | Updated Report | 2020-01-27 | 99690 |
| ETIBI | BAUSCH HEALTH, CANADA INC. | Actual shortage | 400MG | Updated Report | 2020-01-27 | 85831 |
| ETIBI | BAUSCH HEALTH, CANADA INC. | Actual shortage | 100MG | Updated Report | 2020-01-27 | 85828 |
| MINT-FLUOXETINE | MINT PHARMACEUTICALS INC | Actual shortage | 20MG | Updated Report | 2020-01-27 | 57069 |
| MINT-LOSARTAN/HCTZ DS | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG 100.0MG | Updated Report | 2020-01-27 | 80811 |
| MINT-LOSARTAN/HCTZ | MINT PHARMACEUTICALS INC | Resolved | 12.5MG 50MG | Updated Report | 2020-01-27 | 74450 |
| XYLOCAINE 1% | ASPEN PHARMACARE CANADA INC. | Actual shortage | 10MG | Updated Report | 2020-01-27 | 99693 |
| MINT-LOSARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 12.5MG 100MG | Updated Report | 2020-01-27 | 80808 |
| MINT-PIOGLITAZONE | MINT PHARMACEUTICALS INC | Actual shortage | 15MG | Updated Report | 2020-01-27 | 88502 |
| MINT-PIOGLITAZONE | MINT PHARMACEUTICALS INC | Actual shortage | 30MG | Updated Report | 2020-01-27 | 95924 |
| MINT-LOSARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG | Updated Report | 2020-01-27 | 71069 |
| MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 12.5MG 150.0MG | Updated Report | 2020-01-27 | 80792 |
| MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 300MG | Updated Report | 2020-01-27 | 80803 |
| MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 75MG | Updated Report | 2020-01-27 | 71063 |
| MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Actual shortage | 150MG | Updated Report | 2020-01-27 | 80800 |
| MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Actual shortage | 25.0MG 300.0MG | Updated Report | 2020-01-27 | 80797 |
| MINT-FLUOXETINE | MINT PHARMACEUTICALS INC | Actual shortage | 10MG | Updated Report | 2020-01-27 | 57064 |
| MINT-CIPROFLOX | MINT PHARMACEUTICALS INC | Actual shortage | 500MG | Updated Report | 2020-01-27 | 57055 |
| NARDIL | ERFA CANADA 2012 INC | Actual shortage | 15MG | New Report | 2020-01-27 | 104431 |
| THYROID TAB 30MG | ERFA CANADA 2012 INC | Resolved | 30MG | Updated Report | 2020-01-27 | 101408 |
| TENORETIC 50/25MG TAB | ASTRAZENECA CANADA INC | Anticipated shortage | 25MG 50MG | Updated Report | 2020-01-27 | 104426 |
| VINBLASTINE SULPHATE INJECTION | TEVA CANADA LIMITED | Resolved | 1MG | Updated Report | 2020-01-27 | 98185 |
| LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ | BAXTER CORPORATION | Actual shortage | 50MG 4MG | Updated Report | 2020-01-27 | 101629 |
| SEPTA-LOSARTAN | SEPTA PHARMACEUTICALS INC | Actual shortage | 25MG | Updated Report | 2020-01-27 | 72089 |
| SEPTA-LOSARTAN | SEPTA PHARMACEUTICALS INC | Actual shortage | 100MG | Updated Report | 2020-01-27 | 70874 |
| TENORETIC 100/25MG TAB | ASTRAZENECA CANADA INC | Anticipated shortage | 25MG 100MG | Updated Report | 2020-01-27 | 104401 |
| SEPTA-LOSARTAN | SEPTA PHARMACEUTICALS INC | Actual shortage | 50MG | Updated Report | 2020-01-27 | 62907 |
| HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | PFIZER CANADA ULC | Resolved | 2UNIT | Updated Report | 2020-01-27 | 98220 |
| APO-ABACAVIR-LAMIVUDINE | APOTEX INC | Resolved | 600MG 300MG | Updated Report | 2020-01-27 | 92016 |
| TEVA-LENOLTEC NO. 4 | TEVA CANADA LIMITED | Resolved | 300MG 60MG | Updated Report | 2020-01-25 | 101145 |
| TEVA-LENOLTEC NO. 3 | TEVA CANADA LIMITED | Resolved | 300MG 30MG 15MG | Updated Report | 2020-01-25 | 101707 |
| ZENHALE | MERCK CANADA INC | Resolved | 5MCG 200MCG | Updated Report | 2020-01-25 | 102507 |
| ZYTRAM XL | PURDUE PHARMA | Resolved | 150MG | Updated Report | 2020-01-25 | 103343 |
| TEVA-ROSUVASTATIN | TEVA CANADA LIMITED | Resolved | 20MG | Updated Report | 2020-01-25 | 103561 |
| COPHYLAC | BAUSCH HEALTH, CANADA INC. | Actual shortage | 10MG 20MG | Updated Report | 2020-01-25 | 101027 |
| ATACAND TAB 8MG | ASTRAZENECA CANADA INC | Resolved | 8MG | Updated Report | 2020-01-25 | 103575 |
| ATACAND TAB 16 MG | ASTRAZENECA CANADA INC | Resolved | 16MG | Updated Report | 2020-01-25 | 103581 |
| PROSCAR | MERCK CANADA INC | Anticipated shortage | 5MG | Updated Report | 2020-01-24 | 102400 |
| ACT ANASTROZOLE | TEVA CANADA LIMITED | Actual shortage | 1MG | New Report | 2020-01-24 | 104374 |
| TEVA-FLUOXETINE | TEVA CANADA LIMITED | Actual shortage | 20MG | New Report | 2020-01-24 | 104371 |
| TEVA-TOPISONE | TEVA CANADA LIMITED | Actual shortage | 0.05% | New Report | 2020-01-24 | 104368 |
| TEVA-TOPILENE | TEVA CANADA LIMITED | Actual shortage | 0.5MG | New Report | 2020-01-24 | 104365 |
| TEVA-TOPISONE | TEVA CANADA LIMITED | Actual shortage | .05% | New Report | 2020-01-24 | 104362 |
| TEVA-CLOBETASOL | TEVA CANADA LIMITED | Actual shortage | 0.05% | New Report | 2020-01-24 | 104359 |
| TEVA-CEPHALEXIN | TEVA CANADA LIMITED | Actual shortage | 500MG | New Report | 2020-01-24 | 104356 |
| TEVA-FULVESTRANT INJECTION | TEVA CANADA LIMITED | Actual shortage | 50MG | New Report | 2020-01-24 | 104353 |
| TEVA-TIAPROFENIC ACID | TEVA CANADA LIMITED | Actual shortage | 300MG | New Report | 2020-01-24 | 104350 |
| TEVA-FUROSEMIDE | TEVA CANADA LIMITED | Actual shortage | 80MG | New Report | 2020-01-24 | 104347 |
| TEVA-ESOMEPRAZOLE | TEVA CANADA LIMITED | Actual shortage | 40MG | New Report | 2020-01-24 | 104344 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| CIPRO | BAYER INC | To be discontinued | 500MG | Updated Report | 2020-01-27 | 96049 |
| AVELOX I.V. | BAYER INC | To be discontinued | 400MG | Updated Report | 2020-01-27 | 73405 |
| TENORETIC 100/25MG TAB | ASTRAZENECA CANADA INC | Reversed | 25MG 100MG | Updated Report | 2020-01-27 | 94999 |
| TENORETIC 50/25MG TAB | ASTRAZENECA CANADA INC | Reversed | 25MG 50MG | Updated Report | 2020-01-27 | 94996 |
| ACT LEVETIRACETAM | TEVA CANADA LIMITED | Discontinued | 500MG | New Report | 2020-01-24 | 104304 |
| ACT PAROXETINE | ACTAVIS PHARMA COMPANY | Discontinued | 20MG | New Report | 2020-01-24 | 104300 |
| TEVA-QUININE | TEVA CANADA LIMITED | Discontinued | 300MG | New Report | 2020-01-24 | 104294 |
| NOVAMOXIN | TEVA CANADA LIMITED | Discontinued | 250MG | New Report | 2020-01-24 | 104289 |
| TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Discontinued | 5MG | New Report | 2020-01-24 | 104283 |
| DEMEROL | SANOFI-AVENTIS CANADA INC | To be discontinued | 50MG | Updated Report | 2020-01-24 | 98380 |
